Leerink Partners Maintains Outperform on Replimune Group, Raises Price Target to $31
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Leerink Partners analyst Daina Graybosch maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $19 to $31.
Leerink Partners analyst Daina Graybosch maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $19 to $31.
